Jerome Thomas, MD
Advanced Heart Failure and Transplant Cardiology · Austin, TXNPI 1225133689
Payments from drug & device makers
Across 1,278 payments — averaging $145.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$144K
- Actelion Pharmaceuticals US, Inc.$22K
- Bayer$5K
- Boehringer Ingelheim$4K
- Abiomed$3K
- Novartis$1K
- plus $6K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 771 | $144,109 |
| Actelion Pharmaceuticals US, Inc. | 80 | $22,267 |
| Bayer | 10 | $5,130 |
| Boehringer Ingelheim | 7 | $4,188 |
| Abiomed | 143 | $3,104 |
| Novartis | 103 | $1,241 |
| Lilly USA, LLC | 2 | $1,040 |
| AstraZeneca | 28 | $916 |
| Pfizer | 24 | $463 |
| Impulse Dynamics (USA) Inc. | 9 | $414 |
| Cvrx, Inc. | 4 | $379 |
| Medtronic(2 entities) | 16 | $372 |
| Kiniksa Pharmaceuticals International, PLC | 13 | $247 |
| Boston Scientific | 3 | $226 |
| Atricure, Inc. | 3 | $226 |
| United Therapeutics Corporation | 15 | $202 |
| Endotronix, Inc. | 1 | $186 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $177 |
| Shockwave Medical, Inc | 2 | $169 |
| Merck | 7 | $129 |
| Alnylam Pharmaceuticals Inc. | 6 | $122 |
| Masimo Corporation | 2 | $89 |
| Heartflow, Inc. | 2 | $65 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| Johnson & Johnson | 5 | $35 |
| Scpharmaceuticals Inc. | 2 | $31 |
| Sanofi | 1 | $24 |
| Novo Nordisk | 1 | $22 |
| Vital Connect, Inc | 1 | $19 |
| GSK | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
How this compares
$185,731 in reported general payments places this provider in the 75th percentile of 75 advanced heart failure and transplant cardiology providers in Texas.
See all advanced heart failure and transplant cardiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Austin
- Kunjan BhattAustin$1.6M
- Clay CauthenAustin$152K
- Raymond BietryAustin$110K
- Andrew ChengAustin$6K
- Robert GottliebDallas$14.1M
- Martin BerkDallas$1.9M
- Ajith NairHouston$1.3M
- Shelley HallDallas$1.3M
- Aasim AfzalPlano$1.2M
- Albert HicksTemple$656K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.